1. Correlation between Platelet α2-Adrenoreceptors and Symptom Severity in Major Depression
- Author
-
Stefano Baroni, Gino Giannaccini, Irene Masala, Donatella Marazziti, E. Di Nasso, Giovanni B. Cassano, Antonio Lucacchini, and Laura Betti
- Subjects
medicine.medical_specialty ,Rauwolscine ,Antagonist ,Hamilton Rating Scale for Depression ,Gastroenterology ,Norepinephrine (medication) ,Psychiatry and Mental health ,chemistry.chemical_compound ,Neuropsychology and Physiological Psychology ,chemistry ,Internal medicine ,medicine ,Catecholamine ,Platelet ,Psychiatry ,Receptor ,Psychology ,Biological Psychiatry ,Depression (differential diagnoses) ,medicine.drug - Abstract
Background: Abnormalities in different parameters of the norepinephrine system have been widely described in major depression. The presence of α2-adrenoreceptors in blood platelets, similar to those in the brain, prompted us to evaluate them in depressed patients, as compared with healthy controls. Methods: Fifteen outpatients affected by major depression, according to DSM IV criteria, and 15 comparable healthy control subjects, were included in the study. The α2-adrenoreceptors were measured by means of the specific binding of [3H]rauwolscine, a highly selective antagonist for this receptor subtype. The severity of depression was assessed by means of the Hamilton Rating Scale for Depression (HRSD). Results: The results did not show any difference in [3H]rauwolscine binding parameters (Bmax and Kd) between patients and controls. However, in the patients, a significant and positive correlation between Bmax, which measures the density of the receptors, and HRSD total score was detected. Conclusions: Therefore, although no change in α2-adrenoreceptors seems to occur in major depression, the density of these receptors would seem to be related to the severity of depressive symptoms.
- Published
- 2001